Stroke in the patient with diabetes (Part 2) – Prevention and the effects of glucose lowering therapies
- 12 May 2020
- journal article
- review article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 164, 108199
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Neuroprotective Effects of Liraglutide for Stroke Model of RatsInternational Journal of Molecular Sciences, 2013
- Rosiglitazone and Outcomes for Patients With Diabetes Mellitus and Coronary Artery Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) TrialCirculation, 2013
- Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2013
- Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled TrialsPLOS Medicine, 2012
- Overcoming limitations of current antiplatelet drugs: A concerted effort for more profitable strategies of interventionAnnals of Medicine, 2011
- Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Provides Neuroprotection in Mice Transient Focal Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2011
- Aspirin for Primary Prevention of Cardiovascular Events in People With DiabetesDiabetes Care, 2010
- Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular EventsNew England Journal of Medicine, 2010
- Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous StrokeStroke, 2007
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002